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Abstract 
There is increasing evidence that vascular risk factors, including aging, hypertension, diabetes 
mellitus and obesity, promote cognitive impairment, however, the underlying mechanisms 
remain obscure. Cerebral blood flow (CBF) is adjusted to neuronal activity via neurovascular 
coupling (NVC) and this mechanism is known to be impaired in the aforementioned 
pathophysiological conditions. To establish a direct relationship between impaired NVC and 
cognitive decline, we induced neurovascular uncoupling pharmacologically in mice by inhibiting 
the synthesis of vasodilator mediators involved in NVC. Treatment of mice with the 
epoxygenase inhibitor MSPPOH, the NO synthase inhibitor L-NAME and the COX inhibitor 
indomethacin decreased NVC by over 60% mimicking the aging phenotype, which was 
associated with significantly impaired spatial working memory (Y-maze), recognition memory 
(Novel object recognition) and impairment in motor coordination (Rotarod). Blood pressure (tail 
cuff) and basal cerebral perfusion (arterial spin labeling perfusion MRI) were unaffected. Thus, 
selective experimental disruption of NVC is associated with significant impairment of cognitive 
and sensorimotor function, recapitulating neurological symptoms and signs observed in brain 
aging and pathophysiological conditions associated with accelerated cerebromicrovascular aging.  
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Introduction  
 Cognitive impairment in the rapidly aging population poses a serious challenge to the 
Western world. As the percent of the population over the age of 65 continues to increase, 
understanding potentially reversible and preventable vascular contributions to age-related 
dementia is of critical importance.  
 There is evidence that in addition to pathologies affecting the larger cerebral arteries(e.g. 
atherosclerosis leading to cerebral ischemia), pathophysiological alterations of the cerebral 
microcirculation also have a critical role in the age-related decline of brain function(1). Among 
them functional changes in the neurovascular unit affecting local regulation of cerebral blood 
flow are of special importance. The energetic demand of neurons is high and the brain has little 
reserve capacity. With increased neuronal activity there is a requirement for rapid increases in 
oxygen and glucose delivery. This is regulated by neurovascular coupling, a feed-forward control 
mechanism adjusting local cerebral blood flow (CBF) to the energy requirements of activated 
neurons(2). The resulting functional hyperemia is responsible for increased delivery of oxygen 
and glucose, effective elimination of noxious substances and ensuring an optimal 
microenvironment in the cerebral tissue. Neurovascular coupling is achieved through an 
orchestrated, tightly controlled intercellular communication between activated neurons and 
astrocytes and vascular endothelial cells, pericytes and smooth muscle cells(2). The cellular 
mechanisms underlying neurovascular coupling include neuronal and endothelial production of 
nitric oxide (NO)(3-5) and astrocytic production of vasodilator metabolites of arachidonic acid, 
including epoxygenase-derived epoxyeicosatrienoic acids (EETs) and cyclooxygenase-derived 
prostaglandins(6-8). 
 Impairment of functional hyperemia (‘neurovascular un-coupling’) due to dysregulated 
production and/or release of NO, EETs and prostaglandins is manifested in aging(9-11) and has 
also been described in a wide spectrum of pathophysiological conditions associated with 
accelerated cerebromicrovascular aging and cognitive impairment, including hypertension(12), 
obesity(13) and Alzheimer’s disease(14) both in humans and experimental animals. Despite 
these advances, the relationship between neurovascular uncoupling and cognitive impairment is 
not completely understood. 
 Although impaired delivery of nutrients and oxygen is expected to adversely affect 
neuronal function, both aging and the aforementioned disease conditions are also associated with 
complex functional and phenotypic alterations both in the neurons and glial cells (including 
synaptic dysfunction, dysregulation of neurotransmitter receptors and post-synaptic signaling 
pathways, impaired cellular metabolism, increased neuroinflammation and neurodegenerative 
consequences of amyloid plaques), which exert multifaceted adverse effects on processes 
involved in higher cortical function(15). Thus, in previous investigations it has been challenging 
to establish the specific role of neurovascular uncoupling in the genesis of cognitive impairment.  
 The present study was designed to test the hypothesis that neurovascular uncoupling 
itself, in the absence of primary neuronal deficit, results in clinically significant alterations of 
cerebral function, including cognitive impairment. To achieve this goal, neurovascular 
uncoupling was induced experimentally in healthy young control mice by treatment with specific 
pharmacological inhibitors of synthesis of NO, EETs and prostaglandins followed by behavioral 
studies indicative for learning and memory, sensorimotor function and gait coordination.  
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Methods 
 All procedures were approved by the Institutional Animal Care and Use Committee of 
the University of Oklahoma Health Sciences Center and were in accordance with the ARRIVE 
guidelines. 
 
Animals and pharmacological treatments  
 Male C57BL/6J mice (5 month old, n=120) were purchased from the Jackson 
Laboratories (Bar Harbor, ME). Animals were housed under specific pathogen-free barrier 
conditions in the Rodent Barrier Facility at University of Oklahoma Health Sciences Center 
under a controlled photoperiod (12 h light; 12 h dark). The animals were assigned into two 
groups: 1) animals with experimentally-induced neurovascular uncoupling receiving 
pharmacological inhibitors to disrupt production of mediators involved in functional hyperemia 
(NO, EETs and prostaglandins) and 2) controls receiving vehicle. To inhibit the production of 
EETs, mice were treated with N-(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide (MS-
PPOH), a specific inhibitor of EET-producing epoxidases(16). Alzet osmotic minipumps (7 
days-1µl/hr, ~200µl total volume, Cat No.: 2001; Durect Corp., Cupertino, CA) were filled with 
MS-PPOH (20mg/kg/day, dissolved in DMSO and diluted to final concentration with 45% 
cyclodextrin(16)) and implanted subcutaneously. Sham operated control animals received 
vehicle. To block production of vasodilator NO, mice were treated with the NO synthase 
inhibitor L-NG-Nitroarginine methyl ester (L-NAME, 100 mg/kg/day; in drinking water)(17). 
Indomethacin (7.5mg/kg/day, p.o.), a non-selective inhibitor of cyclooxygenases, was used to 
disrupt neurovascular coupling by cyxlooxygenase-derived vasodilator arachidonic acid 
metabolites. Indomethacin was dissolved in ethanol and diluted in 5% (w/v) sodium bicarbonate 
solution. The maximum administered daily volume of ethanol was 3 µL per animal. The 
treatments were continued throughout the entire experimental period (7 days). Blood pressure of 
the animals was recorded before the treatment and on day 3 of the treatment period by the tail 
cuff method, as described(18). 
 
Behavioral studies 
 After the animals completely recovered from surgery (day 3) behavioral tasks were 
performed to characterize the effect of pharmacologically-induced neurovascular uncoupling on 
learning and memory, sensory-motor function, gait and locomotion (n=20 in each group).  
 
Spatial memory testing of mice in the Y-maze 
 Animals were tested for spatial working memory in the Y-maze. In brief, a Y-maze 
apparatus, made up of three enclosed transparent Plexiglas arms (40 cm length x 9 cm width x 16 
cm height) with extra-maze visual cues around the maze, was used to assess hippocampal-
dependent spatial recognition memory. The test consisted of two trials separated by an intertrial 
interval (4 h). All mice were transported to the behavioral testing room in their home cages at 
least 1 h before testing. In the first training (acquisition) trial, mice were placed in the maze 
facing the end of a pseudorandomly chosen start arm and allowed to explore the maze for 5 min 
with one of the arms closed (novel arm). Mice were returned to their home cage until the second 
(retrieval) trial, during which they could explore freely all three arms of the maze. The time spent 
in each arm and number of entries were measured and analyzed from video recordings 
(Ethovision, Noldus Information Technology Inc. Leesburg, VA). Mice were required to enter an 
arm with all four paws in order for it to be counted as an entry. Entering the Novel arm more 
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frequently and for longer periods of time indicates intact memory and novelty-seeking behavior 
because of the innate tendency of mice to explore. The maze was cleaned with 70% ethanol 
between the trials.  
 
Novel object recognition test 
 To evaluate recognition memory the novel object recognition task was used. The results of 
the test are influenced by both hippocampal and cortical impairment(19). The test consists of a 
habituation phase, acquisition (familiarization) phase, and trial phase. During the habituation 
phase the animals explored the empty open-field arena for 5 min. Then, in the acquisition phase 
the mice explore two identical objects for 2 minutes. After a 4 h delay, a trial phase occurred. 
During this period animals explored the familiar object and a novel object for 2 min. Exploration 
of the objects was defined as directing the nose at a distance ≤2 cm to the object and/or touching 
it with the nose. Sitting or climbing on it was not considered as an exploration. All objects used 
in this study were made of washable odorless plastic and were different in shapes and colors but 
identical in size. A percent of time spent exploring the novel object relative to the total time 
spent exploring both objects was used as a measure of novel object recognition. The Recognition 
Index (RI, representing the time spent investigating the novel object [Tnovel] relative to the total 
object investigation) was used as the main index of retention, which was calculated according to 
the following formula: [RI = Tnovel/(Tnovel + Tfamiliar)](19). The arena and the objects were cleaned 
with 70% ethanol between the trials to prevent the existence of olfactory cues.    
 
Elevated plus maze learning protocol 
 Mice were also assessed for learning capacity using an elevated plus maze-based learning 
protocol as previously described (18). A gray elevated plus maze was used. Two open arms 
(25x5 cm) and two (25x5 cm) closed arms were attached at right angles to a central platform 
(5x5 cm) 40 cm above the floor. Mice were placed individually at the end of an open arm with 
their back to the central platform. The time for mice to cross a line halfway along one of the 
closed arms was measured (transfer latency) on the first day and the second day. Mice had to 
have their body and each paw on the other side of the line. If a mouse had not crossed the line 
after 120 s, it was placed beyond it. After crossing the line, mice had 30 s to explore the 
apparatus. Learning was defined as reduced transfer latency on day 2 compared to day 1. 
Decreased transfer latency indicates intact hippocampal function. 
 
Rotarod 
 Motor coordination was assessed in control and treated mice by using an automated four-
lane rotarod (Columbus Instruments, Columbus, OH). Mice were pre-trained by placing them on 
the moving rotarod at 10 r.p.m. until they performed at this speed for 120 sec. On the day of 
testing, mice were habituated in their home cages and acclimate to the testing room for at least 
15 min. The test phase consisted of three trials separated by 15 min inter-trial intervals. The 
testing apparatus was set to accelerate from 4 to 40 r.p.m. in 300 seconds. One mouse was then 
placed on each lane and the rotarod was started with an initial rotation of 4 r.p.m. The rotational 
velocity was set to increase every 10 seconds and the latency to fall was recorded. Latency to fall 
was recorded in seconds by an infra-red beam across the fall path along with the max r.p.m. 
sustained by each mouse (20).  
 
Grip strength 
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 To evaluate the effect of neurovascular uncoupling on static force production, forelimb 
grip strength was measured using a computerized electronic pull strain gauge (Grip Strength 
Meter-Columbus Instruments, Columbus, OH)..  
 
Adhesive removal test 
 Sensorimotor function was characterized by the adhesive removal test(21). This test 
consists of applying adhesive tape on each forepaw of the animal and measuring the time-to-
remove. In brief, mice were individually habituated for 20 minutes to a test cage with clean 
bedding. The animals were then removed from the testing box and a pre-cut square piece of tape 
was applied on each animal front paw to cover the hairless part of the forepaws. After the 
adhesive squares were placed with equal pressure on each forepaw, the animals were replaced in 
the testing box and the latency for the mice to remove the pieces of tape was measured with a 
maximum test time of 120s.  
 
Buried food retrieval test 
 To evaluate the effect of neurovascular uncoupling on olfactory ability and gustatory 
motivation we used the buried food retrieval test. Mice deprived of food overnight were put in a 
cage (42 x 25 x 15 cm
2
) in which a food pellet was buried under bedding material and the latency 
to discover it was measured with a maximum of 5 min. The same test was repeated after 1 h with 
a food pellet in a visible position in front of the mouse to exclude motor deficits or motivational 
failure.  
 
Analysis of gait function 
 To determine whether neurovascular uncoupling affects gait coordination, we tested the 
animals using an automated computer assisted method (CatWalk; Noldus Information 
Technology Inc. Leesburg, VA). Using the CatWalk system the detection of paw print size, 
pressure and pattern during volunteer running on an illuminated glass walkway by a camera 
placed under the glass surface provides an automated analysis of gait function and the spatial and 
temporal aspects of interlimb coordination(22). Briefly, animals were trained to cross the 
walkway and then, in a dark room and silent room (<20 lux of illumination), animals were tested 
in three consecutive runs. Data were averaged across three runs in which the animal maintained a 
constant speed across the walkway. After manual identification and labeling of each footprint the 
following indices were calculated. The regularity index (%) is a fractional measure of inter-paw 
coordination, which expresses the number of normal step sequence patterns relative to the total 
number of paw placements. The formula of regularity index is: NSSPx4/PP x 100 (%), where 
NSSP represents the number of normal step sequence patterns and PP the total number of paw 
placements. In healthy, fully coordinated animals its value is 100%. Phase dispersion provides a 
quantitative metric of inter-paw coordination. Phase dispersion characterizes the placement of 
two paws (“target” and “anchor”) during the cycle of consecutive initial contacts with an 
“anchor” paw. In a step cycle base of support gives the distance between the mass-midpoints of 
the fore prints at maximal contact. The results are averaged and expressed in cm. 
 
Measurement of neurovascular coupling responses and somatosensory evoked field potentials 
 After behavioral testing, mice in each group were anesthetized (α-chloralose (50 mg/kg, 
i.p.) / urethane (750 mg/kg, i.p.), endotracheally intubated and ventilated (MousVent G500; Kent 
Scientific Co, Torrington, CT). A thermostatic heating pad (Kent Scientific Co, Torrington, CT) 
8 
 
was used to maintain rectal temperature at 37
o
C (23). End-tidal CO2 (including dead space) was 
controlled between 3.2% and 3.7% to keep blood gas values within the physiological range 
(PaCO2: 37.1±2.4 mmHg, PaO2: 110.8±3.5 mmHg). The right femoral artery was canulated for 
arterial blood pressure measurement (Living Systems Instrumentations, Burlington, VT) (23). 
The blood pressure was within the physiological range throughout the experiments (90-110 
mmHg). Mice were immobilized, placed on a stereotaxic frame (Leica Microsystems Inc, 
Buffalo Grove, IL), the scalp and periosteum were pulled aside. The animals were equipped with 
an open cranial window as described (23) and a glass-insulated tungsten microelectrode 
(impedance, 2–3 MΩ, Kation Scientific, LLC, Minneapolis, MN) was inserted stereotaxically 
into the left barrel cortex (3 mm lateral and 1.5 mm caudal to bregma; depth of 0.6 mm) through 
the ACSF-perfused open cranial window for recording local field potentials. An Ag/AgCl 
electrode inserted in the neck muscles served as reference electrode. Changes in cerebral blood 
flow (CBF) were assessed above the left barrel cortex using a laser Doppler probe (Transonic 
Systems Inc., Ithaca, NY) as described(23). 
 After basal activity was recorded the right whisker pad was stimulated by a bipolar 
stimulating electrode placed to the ramus infraorbitalis of the trigeminal nerve and into the 
masticatory muscles. The stimulation protocol used to investigate neurovascular coupling and 
somatosensory evoked field potentials consisted of 10 stimulation presentation trials with an 
intertrial interval of 70 seconds, each delivering a 30-second train of electrical pulses (2 Hz, 0.2 
mA, intensity, and 0.3 ms pulse width) to the mystacial pad after a 10-second prestimulation 
baseline period. Changes in CBF were averaged and expressed as percent (%) increase from the 
baseline value(12). The electrical signal was amplified with a AC/DC differential amplifier (high 
pass at 1Hz, low pass at 1kHz) (Model 3000, A-M Systems, Inc. Carlsborg, WA), and digitalized 
by the PowerLab/Labchart data acquisition system (ADInstruments, Colorado Springs, CO) with 
the sampling rate of 40 kHz. Analyses were performed on the average of 10 stimulation trials. 
The negative amplitude in the somatosensory evoked field potential response was considered as 
the excitatory postsynaptic potential (fEPSP)(24). Experiments lasted ~20-30 min/mouse, which 
permitted stable physiological parameters to be obtained. The experimenter was blinded to the 
treatment of the animals. In additional experiments the effects of acute topical treatment with 
MS-PPOH (2x10
-6 
mol/L for 30 min), L-NAME (3x10
-4
 mol/L) and indomethacin (10
-5
 mol/L 
for 30 min) on neurovascular coupling in untreated mice was assessed.  
 
Measurement of changes in extracellular glucose concentration in response to whisker 
stimulation  
 In a separate cohort of animals we assessed changes in extracellular glucose 
concentration ( [glucose]ec) in response to whisker stimulation, as a metabolic surrogate of 
cerebral functional hyperemia. Glucose and lactate produced from glucose are the primary 
source of energy of cerebral tissue(25). Because there are no significant glucose reserves, 
neurovascular coupling has a critical role in increasing glucose supply during neuronal and 
astrocytic
 
activation in a feed-forward manner. Thus, measurement of changes in [glucose]ec 
during neuronal activation, which is determined by the balance between cellular consumption 
and changes in CBF, can be used as a metabolic surrogate of cerebral functional hyperemia. In 
brief, a cranial window was prepared in anesthetized mice and the dura was gently removed. The 
cranial window was superfused continuously with ACSF. Glucose microsensors with constant 
potential amperometry were used to measure changes of extracellular glucose concentration in 
response to whisker stimulation. A 3-electrode potentiostat (Quadstat) with an eDAQ data 
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acquisition system (eDAQ Pty Ltd., USA, CO) was used. Before placing the glucose sensor 
(Sarissa GLU Biosensor, 25 µm tip, Sarissa Biomedical, Coventry, UK)(26) into the barrel field 
of the mouse it was calibrated according to the manufacturer guidelines in vitro, then inserted 1.5 
mm caudal and 3 mm lateral from bregma into the cerebral tissue approximately 500 µm deep. 
The glucose sensor is a platinum/iridium wire electrode encapsulated in a bio-layer containing 
glucose oxidase and protected against the interference with ascorbate, urate, dopamine and 5-
hydroxytriptamine. D-Glucose is oxidized into D-glucono-1,5-lactone plus hydrogen peroxide 
which is sensed by the electrode. In a different set of experiments glucose null sensors (lack of 
any enzymes for biosensing) were used as controls. The reference electrode (Ag/AgCl) was 
placed in the cerebral tissue elsewhere and the auxiliary electrode (Ag/AgCl) was between the 
scalp and the skull. Constant potential 0.5 V vs. Ag/AgCl was used. Following the insertion a 
stable baseline developed in 5-10 minutes. Then, the right whiskers were stimulated for 2 minute 
at 5 Hz in 2 consecutive trials divided by 5-10 min intervals. The response was recorded in µA 
and converted to mmol/L of glucose using the calibration curve.  
 
Arterial spin labeling magnetic resonance imaging 
In order to characterize the effect of the drugs used to inhibit neurovascular coupling on 
basal CBF, a separate cohort of control and experimental mice (n=10 in each group) were 
positioned in a stereotaxic cradle for perfusion MRI studies. The animals were anesthetized with 
isoflurane administered through a face-mask and adjusted to maintain respiratory rate in the 
physiological range following published protocols(27). Body temperature was maintained at 
~37°C using a heading pad. A 30 cm horizontal bore Bruker Biospin magnet operating at 7T 
(Bruker BioSpin GmbH, Karlsruhe, Germany) was used with a S116 gradient set. An actively 
decoupled head coil was used for signal detection. The resonator coil was a multirung birdcage 
quadrature coil with an inner diameter of 72mm. Multiple-slice, multiple echo (MSME) imaging 
(TR=2000ms, TE=17.5 or 58.2ms, 156μm/pixel, 2 averages) was used to obtain gross brain 
morphology. Perfusion maps were obtained on a single axial slice of the brain located 1.5 mm 
posterior from bregma on the rostro-caudal axis. The imaging geometry was a 25.6×25.6mm2 
slice of 1.5mm in thickness, with a single shot echo-planar encoding over a 64×64 matrix. An 
echo time of 20ms and a repetition time of 18s were used, and images were not submitted to time 
averaging. To obtain perfusion contrast, the flow alternating inversion recovery scheme was 
used. Briefly, inversion recovery images were acquired using a slice-selective (SS) inversion of 
the same geometry as the imaging slice or a non-selective (NS) inversion slice concentric with 
the imaging slice but of 60mm in thickness. For each type of inversion, 8 images were acquired 
with inversion times (TI) evenly spaced from 20ms to 2820ms. Data processing: Recovery 
curves were obtained as previously reported(28), and obtained from each pixel of the non-
selective (SNS(TI) = A - B·e
-TI/T
1) or selective (Sss(TI) = A - B·e
-TI/T
1
*
, with 1/T1
*
 = 1/T1 + CBF/λ) 
inversion images were numerically fitted to derive the pixelwise T1 and T1* values, respectively. 
The results were stored as maps for further analysis. These longitudinal recovery rates were then 
used to calculate the perfusion by cerebral blood flow, CBF (ml/(100g·min)) on a pixelwise basis 
using the following relationship: CBF = λ · [(1/T1
*
) – (1/T1)]. The perfusion was scaled by 
assigning the generally adopted value of 0.9ml/g (29) to the partition coefficient, λ. Regions of 
interest (ROIs) were manually outlined around the left and right cortex regions of the brain.  
 
Electrophysiological studies: measurement of long-term potentiation (LTP) 
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To determine whether the pharmacological treatment disrupted neuronal mechanisms of 
learning and memory, extracellular recordings were performed from acute hippocampal slices 
with an adopted protocol as originally described(30). Briefly, horizontal hippocampal slices of 
325 µm thickness from mice in each cohort were prepared  in ice cold  solution containing (in 
mmol/L) sucrose 110, NaCl 60, KCl 3, NaH2PO4 1.25, NaHCO3 28, sodium ascorbate acid 0.6, 
glucose 5, MgCl2 7, CaCl2 0.5 using a HM650V vibrating microtome (Thermo Scientific). Slices 
were then transferred to a holding chamber (Scientific Designs, Inc.) which contained 
oxygenated artificial cerebrospinal fluid (aCSF) of the following composition (in mmol/L) NaCl 
126, KCl 2.5, NaH2PO4 1.25, MgCl2 2, CaCl2 2, NaHCO3 26, glucose 10, pyruvic acid 2, 
ascorbic acid 0.4. For in vitro inhibition of synthesis of NO, EETs and prostaglandins MS-PPOH 
(2x10
-6 
mol/L for 30 min), L-NAME (3x10
-4
 mol/L) and indomethacin (10
-5
 mol/L for 30 min) 
were used. Slices were left to recover for at least 60 min at room temperature prior to recording 
in a brain slice chamber (Automate Scientific Inc., CA). Slices from the treatment and control 
groups were positioned on P5002A multi-electrode arrays (Alpha MED Scientific Inc, Japan) 
and perfused with aCSF at a rate of 2 ml/min, equilibrated with 95% O2 and 5% CO2 at 32°C. 
Field excitatory post-synaptic potentials (fEPSPs) were invoked through stimulation of the 
performant path collaterals (0.2 msec biphasic pulse) and obtained from the dentate gyrus area. 
Threshold for evoking fEPSPs was determined and the stimulus was increased incrementally 
until the maximum amplitude of the fEPSP was reached (I/O curve). All other stimulation 
paradigms were induced at the same half-maximal stimulus strength, defined as 50% of the 
stimulus used to produce the maximum fEPSP amplitude, as determined by the I/O curve, for 
each individual slice. After a stable baseline recording of 15 min was established, LTP was 
induced using high-frequency stimulation (HFS), which consisted of 100 pulses at 100 Hz 
applied 4 times with half-minute intervals. fEPSPs were monitored every 30 sec for 60 min 
following HFS and were recorded with MED-64 system and Mobius software (Alpha MED 
Scientific Inc). Potentiation was calculated as the percent increase of the mean fEPSP descending 
slope following HFS and normalized to the mean fEPSP descending slope of baseline recordings. 
 
Statistical analysis 
 Statistical analysis was carried out by unpaired t test or two-way ANOVA for repeated 
measures followed by Bonferroni multiple comparison test, as appropriate, using Prism 5.0 for 
Windows (Graphpad Software, La Jolla, CA). A p value less than 0.05 was considered 
statistically significant. Data are expressed as mean±S.E.M.  
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Results 
 
Pharmacologically-induced neurovascular uncoupling  
 Changes in CBF in the whisker barrel cortex in response to contralateral whisker 
stimulation was significantly decreased by in vivo treatment with MSPPOH+NAME+INDO 
(representative tracings are shown in Fig. 1A, summary data are shown in Fig. 1B)(31). We 
found that acute topical treatment with MSPPOH+NAME+INDO also results in similar 
decreases in the neurovascular coupling response (Fig. 1B). Treatment with 
MSPPOH+NAME+INDO did not affect relative baseline CBF measured by laser Doppler 
flowmetry (p=0.73 MSPPOH+NAME+INDO vs. control).  We also measured changes in 
[glucose]ec during neuronal activation, as a metabolic surrogate of cerebral functional hyperemia. 
We found that [glucose]ec increased in the barrel field of the somatosensory cortex during 
contralateral whisker stimulation in control animals, corresponding to the dynamics of the CBF 
response (Fig 1C-B). In contrast, the glucose response associated with neuronal activation was 
blunted in animals treated with MSPPOH+NAME+INDO (P=0.002 vs control; Fig 1C-B).  
Pharmacological treatments could reduce functional hyperemia by impairing neural 
activity evoked by whisker pad stimulation. To examine this possibility we assessed the effects 
of treatment with MSPPOH+NAME+INDO by recording spontaneous and evoked neural 
activity. We found that the amplitude and frequency distribution of the electrocorticogram (not 
shown Is it not what you shown in Figure 1E?) and the amplitude of the somatosensory field 
potentials produced by activation of the whisker pad do not differ between control and 
MSPPOH+NAME+INDO treated mice and are also unaffected by acute administration of 
MSPPOH+NAME+INDO into the cranial window (Fig. 1E-F). Therefore, treatment with 
MSPPOH+NAME+INDO is unlikely to contribute to impaired functional hyperemia by 
modulating the neural activity evoked by whisker stimulation.  
 Pharmacologically-induced impairment of neurovascular coupling responses was an 
isolated phenomenon, which does not appear to be associated with changes in systemic 
hemodynamic parameters. Accordingly, the blood pressure of the two groups of animals did not 
differ significantly (control: 106±2 mmHg; MSPPOH+NAME+INDO treated: 107±3 mmHg; 
P=0.49). Further, perfusion mapping of cerebral coronal slices in each group of animals was 
performed by MRI 1-1.5 mm posterior from the bregma, which corresponds to the barrel field of 
the primary somatosensory cortex. We found that calculated CBF values did not differ between 
the control and MSPPOH+NAME+INDO groups (p=0.139; Fig.1E-F). 
 
Induction of neurovascular un-coupling is associated with impaired cognitive function 
 For the hippocampus-dependent spatial memory test control mice spent significantly (P= 
0.006) more time in the novel arm than the previously visited arms following the intertrial 
interval. Mice treated with MSPPOH+NAME+INDO spent significantly less time in the novel 
arm (Fig. 2B). Only the control mice entered the novel arm more often than the previously 
visited arms (p=0.001 vs. Other arm; Fig. 2A), whereas mice treated with 
MSPPOH+NAME+INDO did not (p=0.36 Novel arm vs. Other arm), indicating that 
experimentally-induced neurovascular uncoupling leads to impaired spatial working memory and 
novelty-seeking behavior. 
 We also evaluated hippocampal-dependent learning and memory employing the elevated 
plus-maze. For control mice, transfer latency on Day 2 was significantly decreased (by ~37%; 
P=0.027) compared to Day 1 (Fig. 2C), indicating an intact learning effect. In contrast, for mice 
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treated with MSPPOH+NAME+INDO the transfer latency on day 1 and day 2 were similar 
(p=0.71 1
st
 day vs. 2
nd
 day), indicating impaired learning capability.  
 Subsequently we also tested the performance of the mice in the novel object recognition 
test.  We found no significant difference in the time that mice from each group spent exploring 
the two identical objects placed at the opposite ends of the arena during the acquisition phase, 
confirming that the location of the objects did not affect the exploration behavior of mice. In the 
trial phase with two different objects (one novel, the other familiar), control mice explored the 
novel object for a significantly longer time period, with a calculated Recognition Index (RI) of 
70±2.8%, indicating their memory for the familiar object (Fig. 2D). In contrast, mice treated with 
MSPPOH+NAME+INDO had a lower RI at 59±4 % (p=0.03). This result is consistent with their 
impaired hippocampal- and cortical-dependent recognition memory (Fig. 2D). 
 
Effects of neurovascular un-coupling on sensorimotor function and gait coordination 
 In addition to impaired spatial learning and memory sensorimotor deficits are the most 
common consequences of the aging process in the central nervous system both in humans and 
laboratory animals. We found that mice treated with MSPPOH+NAME+INDO had impaired 
motor performance on Rotarod compared to control mice, as shown by a significant decrease in 
latency to fall (p=0.031 vs. Control) from the rotating lanes of the Rotarod and they also fell at 
lower velocity (r.p.m.) (p=0.021 vs. Control) (Fig 3A-B).  
 Static force production activates a network of sensorimotor cortical and subcortical regions, 
which is associated with increases in local CBF in humans(32). Further, pathological conditions, 
which lead to neurovascular uncoupling (e.g. obesity), are often associated with impaired grip 
strength in humans(33). We found that static force production was also significantly decreased in 
mice treated with MSPPOH+NAME+INDO (p=0.01 vs. Control; Fig 3 C).  
 To further evaluate sensory-motor function, we also performed the adhesive removal test. 
We found that although there was a trend for increased latency to remove the tactile stimulus 
from the paws (Fig 3D) in mice treated with MSPPOH+NAME+INDO, the difference did not 
reach statistical significance.  
 Despite the presence of significant odor-evoked functional hyperemia in mice(34) we 
found that the combined inhibition of synthesis of NO, prostaglandins and EETs does not affect 
olfactory ability and gustatory motivation (p=0.4 vs. control;  Fig.3E).   
 Gait coordination is a higher integrative process of the sensorimotor system. Clinical 
studies suggest that neurovascular coupling may be involved in preservation of gait function in 
elderly people (35). Yet, in the present study we did not observe differences between control 
mice and mice treated with MSPPOH+NAME+INDO in parameters indicative of gait 
(Regularity index p=0.43 vs. control, Base of support p = 0.32 vs. control, Phase dispersion LF-
RF p=0.56, LH-RH p=0.12, LF-RH p=0.88, RF-LH p=0.61; Figure 3 F-K).   
 
No direct changes in synaptic mechanisms of hippocampal learning and memory  
 In order to determine whether treatment with MSPPOH+NAME+INDO directly affects 
major cellular mechanisms underlying learning and memory we measured long-term potentiation 
in the dentate gyrus in hippocampal brain slice preparations following 4x100Hz tetanic 
stimulation of the perforant pathway. fEPSP slope increased similarly in control and 
MSPPOH+NAME+INDO treated groups (p=0.93) during the 60 min experimental period (Fig. 
4). In order to add further ex vivo data to the in vivo evoked field potential responses we also 
measured field excitatory postsynaptic potential in the dentate gyrus to electrical stimulation of 
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the perforant pathway (with 5 µA steps increased up to 100 µA). We found that the ratio of 
evoked responses to the presynaptic fiber volley were similar in both groups (p=0.78), showing 
that the pharmacological treatment does not affect neuronal EPSP. Collectively, these results 
indicate that there are no significant differences in synaptic function and neuronal mechanisms of 
learning and memory between the two experimental groups.   
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Discussion  
 This is the first study, to our knowledge, to demonstrate that pharmacologically-induced 
neurovascular un-coupling in mice is associated with cognitive impairment that mimic behavioral 
alterations present in mouse models of aging and age-related diseases.  
 Population-based studies show that vascular risk factors are associated with significantly 
elevated risk for late life cognitive decline(36). Moreover, evidence exists that microvascular health 
is critical to delaying the onset of vascular cognitive impairment(36). Research to date suggests a 
complex interaction between vascular risk factors, cerebromicrovascular pathologies and the 
pathogenesis of cognitive decline, in which neurovascular un-coupling likely play a critical role. 
 In the present study we demonstrate that pharmacological inhibition of synthesis of EETs, 
prostaglandins and NO leads to significant neurovascular un-coupling, characterized by intact 
evoked field responses which associate with impaired CBF responses induced by synaptic 
activity (Fig. 1). This experimentally-induced neurovascular un-coupling mimics impairment of 
functional hyperemia observed in aging(23) and pathophysiological conditions associated with 
accelerated cerebromicrovascular aging, including  hypertension(12), obesity(13) and 
Alzheimer’s disease(14). The physiological consequences of neurovascular un-coupling are 
likely multifaceted. Here we show that neurovascular uncoupling is associated with impaired 
delivery of glucose to the activated brain region (Fig. 1). Although the relatively modest changes 
in extracellular glucose levels are likely not directly related to impaired cortical function 
associated with neurovascular uncoupling, they serve as a metabolic surrogate of the impaired 
hyperemic response. On the basis of previous studies(37,38) we predict that impaired 
neurovascular coupling may result in impaired nutrient delivery, inadequate wash-out of by-
products and/or altered local microenvironment in the cerebral tissue, all of which may adversely 
affect neuronal function.  
 The present study provides evidence that neurovascular uncoupling is associated with 
cognitive impairment.  This is complementary to previous data demonstrating that global 
reduction of basal cerebral blood flow also leads to significant learning deficits(39). We found 
that pharmacological inhibition of synthesis of EETs, prostaglandins and NO associates with 
impaired performance in tests relevant for hippocampal- and/or cortical-dependent tasks of 
learning and memory (Fig.2), suggesting that neurovascular un-coupling predicts cognitive 
decline. Our findings have important clinical relevance. First, a wide range of pathophysiological 
conditions were shown to adversely affect the synthesis of vasodilator NO, EETs and/or 
prostaglandins, promoting neurovascular un-coupling. For example, several cardiovascular risk 
factors, including hypertension, dyslipidaemia, smoking and obesity, which are important risk 
factors for cognitive decline in elderly patients(36,40), were shown to decrease the 
bioavailability of NO in the microcirculation by promoting oxidative stress, uncoupling 
endothelial NO synthase and/or by up-regulating asymmetric dimethylarginine (ADMA), an 
endogenous inhibitor of NO synthase. Aging itself was shown to cause neurovascular un-
coupling, at least in part, by impairing NO mediation of the response(23,31). Increased oxidative 
stress and endothelial dysfunction are also known to affect arachidonic acid metabolism, 
decreasing production of vasodilator prostaglandins and EETs and up-regulating production of 
vasoconstrictor metabolites of arachidonic acid, such as 20-hydroxyeicosatetraenoic acid (20-
HETE). Impaired synthesis/release of vasodilator arachidonic acid metabolites have been 
implicated in neurovascular un-coupling associated with IGF-1 deficiency (Toth and Ungvari, 
unpublished data 2014) and cerebral ischemia, as well. All of the aforementioned 
pathophysiological conditions are associated with cognitive decline in experimental animals 
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and/or human patients. On the basis of our findings we posit that therapeutic approaches that 
promote microvascular health and improve neurovascular coupling should exert beneficial 
effects on cognitive function. Recent findings provide initial support for this concept showing 
that pharmacological interventions (e.g. treatment with resveratrol) that restore endothelial 
function and neurovascular coupling(23) can improve cognitive function in aging(41). Second, 
pharmacological treatments and dietary and lifestyle factors that interfere with synthesis of 
vasodilator NO, EETs and/or prostaglandins impair neurovascular coupling and thereby 
adversely affect cognitive function. For example, pharmacological inhibitors of the synthesis of 
vasodilator arachidonic acid metabolites were shown to impair neurovascular coupling in 
humans(38,42). The available data from the Baltimore Longitudinal Study on Aging also suggest 
that use of the cyclooxygenase inhibitor aspirin is associated with greater prospective cognitive 
decline(43). Third, our findings provide strong evidence that neurovascular un-coupling induced 
by systemic influences and detected in the somatosensory cortex can predict impairment of 
cortical and hippocampal function. This result has important relevance for the interpretation of 
results from human studies, in which alterations of neurovascular coupling are often 
characterized in the somatosensory cortex or in the primary visual cortex in the occipital lobe in 
response to visual stimuli(42). Further studies are needed to provide direct evidence that findings 
obtained in the somatosensory cortex extend to other brain regions. The findings that 
experimentally induced neurovascular uncoupling is also associated with sensorimotor deficits 
(Fig. 3) warrants further studies investigating the role of impaired functional hyperemia in age-
related slowing of sensorimotor processes. It is possible that functional consequences of 
neurovascular un-coupling show regional heterogeneity, which also should be elucidated by 
future investigations. There are excellent clinical studies, including the MOBILIZE Boston 
study(35), linking neurovascular un-coupling to gait dysfunction. In the present study 
experimentally induced neurovascular un-coupling did not result in significant changes in the 
investigated indices of gait coordination (Figure 3). It is likely that the effects of acute 
neurovascular un-coupling on gait coordination in mice, if any, are subtle. Investigating gait 
variability, the stride-to-stride fluctuations in gait parameters, offers a more sensitive method of 
quantifying subtle changes in locomotion in mice, which should be considered in future studies. 
Finally, our results may also have important implications for functional brain imaging in which 
functional hyperemia is commonly used as a surrogate for neural activation. 
 There is several line of evidence in support the concept that induction of neurovascular 
un-coupling is the main mechanism by which inhibition of synthesis of EETs, prostaglandins and 
NO impairs cerebral function. Importantly, the pharmacological treatments employed did not 
affect evoked potential responses in the barrel cortex and basic synaptic transmission parameters 
and the normal LTP response of fEPSPs in the hippocampus (Fig. 4). Previous studies also did 
not report significant changes in neuronal activity, including somatosensory evoked potentials, 
after pharmacologically-induced acute neurovascular uncoupling using inhibitors of NO 
synthesis, MS-PPOH and indomethacin(37). It is also unlikely that impairment in learning and 
memory induced by short-term treatment with pharmacological inhibitors involves impaired 
neurogenesis. 
 
Limitation of the studies 
 We cannot exclude the possibility that the inhibition of synthesis of NO, prostaglandins 
and EETs may also affect other aspects of neural, glial or vascular mechanisms, which were not 
investigated in our studies. Although our studies demonstrate an association between 
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pharmacologically-induced neurovascular un-coupling and cognitive decline, further studies are 
needed to establish the cause and effect relationship.  
  
 Collectively, combined inhibition of synthesis of NO, EETs and prostaglandins 
significantly reduces the blood flow responses to neuronal activation in the mouse brain, which 
mimics neurovascular uncoupling observed in aging and pathophysiological conditions 
associated with accelerated cerebromicrovascular aging. The results of this study provide 
evidence that neurovascular un-coupling associates with cognitive decline. Our findings, taken 
together with the results of earlier studies, point to potential benefits of pharmacological and 
dietary interventions promoting microvascular health for prevention of cognitive decline.  
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Legends 
 
 
Figure 1. Experimentally induced neurovascular uncoupling in mice. Panel A: 
Representative traces of cerebral blood flow (CBF) measured with a laser Doppler probe above 
the whisker barrel cortex during electrical stimulation of the contralateral whisker pad (current: 
0.2 mA, pulse duration: 0.3 ms, at 2Hz for a 30 s period) before (left) and after (middle) topical 
administration of MSPPOH, L-NAME plus indomethacin (INDO; see Methods) through the 
cranial window. Right: representative trace of CBF response obtained in a mouse treated 
chronically with MSPPOH, L-NAME plus INDO (see Methods). B: Bar graphs depict the 
summary data of the effect of MSPPOH+NAME+INDO treatment on CBF responses to whisker-
stimulation. Data are mean±S.E.M. (control: n=9, treated: n=6, *p<0.01 vs. Control). Panel C: 
Original recordings of changes in extracellular glucose ([glucose]ec) in response to whisker 
stimulation (5 Hz, 2 min) measured by amperometry using a glucose biosensor inserted into the 
barrel cortex of mice treated with MSPPOH+NAME+INDO or vehicle. “0 sensor”: signal 
obtained with a biosensor constructed the same way as the glucose sensors, without the enzymes 
necessary for biosensing. Summary data are shown in Panel D. In animals treated with 
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MSPPOH+NAME+INDO the glucose response elicited by whisker stimulation was significantly 
decreased. Data are mean±S.E.M. (n=6 in each group, *p=0.002 vs. Control). E: Representative 
recordings showing the effect of treatment with MSPPOH+NAME+INDO on somatosensory 
evoked potential (SEP) responses in the primary somatosensory cortex in response to electrical 
stimulation of the contralateral whisker pad in control and treated groups. Amplitude peaks of 
SEP are labeled P1 and N1 to reflect their polarity and sequence. Inlet shows spontaneous 
cortical electric activity. F: The amplitudes of the negative waves (N1) were unaffected by either 
acute administration of MSPPOH+NAME+INDO in the cranial window (n=6, p=0.2) or chronic 
treatment of the mice with MSPPOH+NAME+INDO (control: n=9, treated: n=6, p=0.4). Panel 
G shows T1 weighted morphological MRI scans and the corresponding perfusion map in the 
brain of a control and a MSPPOH+NAME+INDO treated mouse. The slice is located 1-1.5 mm 
posterior from bregma, the yellow circles show ROIs placed on the barrel field where cerebral 
blood flow (CBF, ml/100 g x min) measurements were taken. Summary data for basal perfusion  
(mean±S.D.; n=10 in each group) are shown in Panel H (n.s.: p=0.139). 
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Figure 2. Neurovascular uncoupling impairs learning and memory. Panels A-B: Spatial 
memory testing of mice in Y-maze. The inset shows schematic picture of the Y-maze with extra-
maze cues used for testing spatial memory (x: start arm, y: other arm, z: novel arm, see details in 
text). Number of entries in novel arm (A; *p=0.006 vs. other arm in control mice) and 
exploratory time spent in novel arm of the Y maze during retrieval trial (B; and p=0.001 vs. 
other arm in control mice) are shown. Mice treated with MSPPOH+NAME+INDO exhibited 
impaired spatial memory as shown by the similar number of entries (p=0.46) and exploratory 
time (p=0.36) spent in novel arm and the other arm of Y maze during the retrieval trial. Data are 
mean±S.E.M. (n=20 in each group). Panel C: Neurovascular uncoupling impairs learning ability, 
as assessed using the elevated plus maze-based learning protocol (see Methods for details). 
Control mice exhibited significantly decreased transfer latency on Day 2 (*p=0.027 vs. Day 1) 
indicating intact hippocampal-dependent learning. For mice treated with 
MSPPOH+NAME+INDO transfer latency was similar on Days 1 and 2 (p=0.71) indicating that 
these mice had significantly impaired learning ability. Data are mean±S.E.M. (n=20 in each 
group).  D: The novel object recognition task test is used to evaluate recognition memory in mice 
(inset). During the habituation phase the animals explored the empty open-field arena for 5 min. 
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Then, in the acquisition phase the mice explored two identical objects during 2 minutes. After a 4 
h delay, a trial phase occurred. The Recognition Index (representing the time spent investigating 
the novel object relative to the total object investigation) was used as the main index of retention. 
Data are mean±S.E.M. (n=20 in each group).  *P<0.05 vs. control.  
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Figure 3. Effects of neurovascular uncoupling on sensorimotor function. Panels A-B: 
Rotarod testing. Time to fall during the accelerating rotarod test (Panel A) and maximal speed at 
fall (Panel B) are shown. Mice treated with MSPPOH+NAME+INDO showed impaired 
performance (time to fall, *p=0.031 vs. control; maximal speed at fall, *p=0.021 vs. control). 
Data are mean±S.E.M.. (n=20 in each group). C: Grip test. Average grip force was significantly 
less in mice treated with MSPPOH+NAME+INDO as compared to control mice (p=0.01 vs. 
Control). Data are mean±S.E.M. (n=20 in each group). There were no significant differences 
between the time needed to remove the adhesive from the forepaw (Panel D, p=0.3 vs. Control) 
or the time needed to retrieve buried food  (Panel E; p=0.4 vs. Control). Data are mean±S.E.M. 
(n=20 in each group). Panels F-K: Effects of neurovascular uncoupling on gait coordination.  A 
similar sequence regularity index (F; p=0.43 vs. Control) reflects no change in step patterns. 
Treatment with MSPPOH+NAME+INDO did not affect base of support (G). Phase dispersions 
(H-K) are unaltered for both the diagonal and the girdle pairs, showing no change in inter-paw 
coordination (LH, left hind limb; RH, right hind limb; LF, left forelimb; RF, right forelimb; n=20 
in each group). 
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Figure 4. Treatment with MSPPOH+NAME+INDO does not affect synaptic function. Panel 
A: Original recordings showing the effects of treatment with MSPPOH+NAME+INDO on field 
EPSP in the dentate gyrus in response to the stimulation of the perforant pathway (to 50 µA) on 
hippocampal brain slices before (10 min) and 1 hour after (70 min) 4x100Hz tetanus. B: Ratio of 
the evoked EPSP responses and the presynaptic fiber volley (I/O ratio) as function of stimulus 
intensity in the dentate gyrus of hippocampal slices. Data are mean±S.E.M. (control, n=11; 
MSPPOH+NAME+INDO treated, n=7; p=0.78). C: Long term potentiation shown as change of 
fEPSP slope following a 4x100Hz tetanic stimulus in the dentate gyrus of the hippocampus. Data 
are normalized to baseline responses and depicted as mean±S.E.M. (control, n=11; 
MSPPOH+NAME+INDO treated, n=7; p=0.93). 
 
